Literature DB >> 28700254

Diquafosol Delivery from Silicone Hydrogel Contact Lenses: Improved Effect on Tear Secretion.

Carmen Dominguez-Godinez1, Gonzalo Carracedo1, Jesus Pintor2.   

Abstract

PURPOSE: The aim of this study was to evaluate the ability to uptake and to deliver diquafosol from commercial contact lenses (CLs) and its effect on tear secretion.
METHODS: For both in vitro and in vivo experiments, two commercial silicone hydrogel (Si-Hy) CLs (comfilcon A and balafilcon A) were used. The CLs were soaked overnight for 12 h in diquafosol solution and control CLs were soaked in saline solution (NaCl 0.9%). The CLs were introduced into a new well container with 1 mL of saline solution, and aliquots of 100 μL were extracted at different times during a period of 6 h to measure the diquafosol release. For in vivo experiments, nine male New Zealand white rabbits were used. CLs soaked in diquafosol were inserted in the eye and compared with control CLs and diquafosol topical instillation. Schirmer's tests were performed to evaluate tear secretion and diquafosol release at different times during the 6-h period.
RESULTS: For in vitro experiments, the largest amount of diquafosol was released during the first 24 h for both CL materials under study, without statistical differences between them (P < 0.05). The topical application showed the maximum release at 1 min after instillation, meanwhile the release from both CL materials was at 30 min of insertion. The effect on tear secretion was higher with CL delivery compared with topical instillation (P < 0.05), being 300 min for both CLs and 90 min for topical application.
CONCLUSION: The use of CLs increases the residence time of diquafosol on the ocular surface with a concomitant enhancement in tear secretion during longer periods.

Entities:  

Keywords:  P2Y2 receptors; Up4U; contact lens; delivery; dinucleoside polyphosphate; diquafosol

Mesh:

Substances:

Year:  2017        PMID: 28700254     DOI: 10.1089/jop.2016.0193

Source DB:  PubMed          Journal:  J Ocul Pharmacol Ther        ISSN: 1080-7683            Impact factor:   2.671


  5 in total

1.  Contact Lenses Loaded with Melatonin Analogs: A Promising Therapeutic Tool against Dry Eye Disease.

Authors:  Francisco Javier Navarro-Gil; Fernando Huete-Toral; Carmen Olalla Domínguez-Godínez; Gonzalo Carracedo; Almudena Crooke
Journal:  J Clin Med       Date:  2022-06-17       Impact factor: 4.964

2.  Melatonin-Eluting Contact Lenses Effect on Tear Volume: In Vitro and In Vivo Experiments.

Authors:  María Serramito; Ana F Pereira-da-Mota; Carlos Carpena-Torres; Fernando Huete-Toral; Carmen Alvarez-Lorenzo; Gonzalo Carracedo
Journal:  Pharmaceutics       Date:  2022-05-09       Impact factor: 6.525

3.  In vivo drug delivery via contact lenses: The current state of the field from origins to present.

Authors:  Liana D Wuchte; Stephen A DiPasquale; Mark E Byrne
Journal:  J Drug Deliv Sci Technol       Date:  2021-02-18       Impact factor: 5.062

Review 4.  Role of the Purinergic P2Y2 Receptor in Pulmonary Hypertension.

Authors:  Mazen Shihan; Tatyana Novoyatleva; Thilo Lehmeyer; Akylbek Sydykov; Ralph T Schermuly
Journal:  Int J Environ Res Public Health       Date:  2021-10-20       Impact factor: 3.390

5.  Efficacy of Artificial Tears Based on an Extract of Artemia salina Containing Dinucleotides in a Rabbit Dry Eye Model.

Authors:  Carlos Carpena-Torres; Jesus Pintor; Fernando Huete-Toral; Alba Martin-Gil; Candela Rodríguez-Pomar; Alejandro Martínez-Águila; Gonzalo Carracedo
Journal:  Int J Mol Sci       Date:  2021-11-05       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.